ImmunityBio, Inc.

IBRX · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $8.8B · 691 employees
175
SEC Filings
$7.95
Close 2026-09-02
691
Employees

Business Summary

ImmunityBio, Inc. (IBRX) is a clinical-stage biopharmaceutical company focused on developing next-generation therapies and vaccines that harness the immune system to combat cancers and infectious diseases. Its approved product, ANKTIVA, is commercialized for BCG-unresponsive non-muscle-invasive bladder cancer (NMIBC). The company's Cancer BioShield platform encompasses cytokine fusion proteins, DNA and recombinant protein vaccines, and cell therapies including NK cell-based treatments.

Latest Stock Quote

IBRX 2026-09-02 $7.95 O:$7.945 H:$8.28 L:$7.755 Vol:7.2M VWAP:$7.9379
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-08-12

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-232025-12-310001326110-26-000030EDGAR153K words
2025-03-032024-12-310001326110-25-000033EDGAR159K words
2024-03-192023-12-310001326110-24-000037EDGAR144K words
2023-03-012022-12-310001326110-23-000018EDGAR139K words
2022-03-012021-12-310001326110-22-000011EDGAR—
2021-03-042020-12-310001564590-21-010945EDGAR—
2020-03-252019-12-310001564590-20-012816EDGAR—
2019-03-132018-12-310001564590-19-007562EDGAR—
2018-03-122017-12-310001564590-18-005290EDGAR—
2017-03-152016-12-310001564590-17-004430EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-042026-06-300001326110-26-000079EDGAR93K words
2025-11-052025-09-300001326110-25-000139EDGAR110K words
2025-08-052025-06-300001326110-25-000114EDGAR109K words
2025-05-122025-03-310001326110-25-000071EDGAR103K words
2024-11-122024-09-300001326110-24-000111EDGAR96K words
2024-08-122024-06-300001326110-24-000103EDGAR94K words
2024-05-092024-03-310001326110-24-000064EDGAR88K words
2023-11-092023-09-300001326110-23-000147EDGAR98K words
2023-08-082023-06-300001326110-23-000098EDGAR93K words
2023-05-112023-03-310001326110-23-000064EDGAR87K words
2022-11-092022-09-300001326110-22-000074EDGAR—
2022-08-082022-06-300001326110-22-000058EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-040001326110-26-000077EDGAR4K words
2026-07-300001326110-26-000071EDGAR3K words
2026-04-060001193125-26-142932EDGAR1K words
2026-03-310001193125-26-133363EDGAR1K words
2026-02-230001326110-26-000025EDGAR5K words
2026-02-180001326110-26-000018EDGAR2K words
2026-01-260001326110-26-000014EDGAR1K words
2026-01-150001326110-26-000008EDGAR1K words
2026-01-140001326110-26-000004EDGAR1K words
2025-12-290001193125-25-331244EDGAR1K words

175 total filings indexed. 143 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

oncology---bladder-cancer-(nmibc) oncology---non-small-cell-lung-cancer-(nsclc) infectious-diseases cell-therapy cancer-vaccines cgmp-(current-good-manufacturing-practice)

Company Identity

CIK0001326110
TickerIBRX
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.immunitybio.com
Listed2021-03-10

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 217ca71f3173112855adcdc22a010805af64bd40000e06604f630b2053dac2da
parent: 2b5274f474e096c47d3e4618479574ce666aa37d9571018b61e582ed8c647612
content hash: 95ca6926528da0e5e3120bc60abfccebe316103858b32dbafb986af764d9e6e8
signed: 2026-09-29T12:01:48.563Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up IBRX using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on IBRX, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/IBRX (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.